Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2026 08:00 ET | Source: Provectus Biopharmaceuticals Inc.

Provectus Biopharmaceuticals and VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular Infections

New IP covers topical rose bengal sodium ophthalmic composition against MRSA and other resistant Gram-positive bacteria without requiring light activation. VisiRose to hold exclusive ophthalmic...
June 30, 2026 01:00 ET | Source: F. Hoffmann-La Roche Ltd

FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)

The filing application is based on improvements seen across key efficacy endpoints from the global phase III SatraGO-1 and SatraGO-2 studies, including proptosis (bulging eyes) and diplopia (double...
June 29, 2026 17:17 ET | Source: Zoumalan, MD FACS Inc.

Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results

Beverly Hills, CA, June 29, 2026 (GLOBE NEWSWIRE) -- Zoumalan, MD FACS Inc. today announced its trademarked Natural Looking Blepharoplasty® approach to eyelid rejuvenation as growing demand for...
June 29, 2026 08:00 ET | Source: 4D Molecular Therapeutics, Inc.

4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD

4FRONT-2 global enrollment completed approximately 4 months ahead of initial projections4FRONT-2 over-enrolled (anticipated N>500), with final patient randomization expected in Q3 2026, reflecting...
June 29, 2026 07:00 ET | Source: NovaBridge Biosciences

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for...
June 29, 2026 01:00 ET | Source: F. Hoffmann-La Roche Ltd

Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform

AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes the freedom to customise their workflows and explore a wider array of...
June 26, 2026 07:00 ET | Source: Jade Biosciences

Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors

SAN FRANCISCO and VANCOUVER, British Columbia, June 26, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (the “Company” or “Jade”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on...
June 25, 2026 08:00 ET | Source: Provectus Biopharmaceuticals Inc.

Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)

Under Veripure, Provectus is supplying qualified medical researchers with the same pharmaceutical grade rose bengal sodium API used in clinical trials.Veripure is also a quality benchmark,...
June 25, 2026 07:00 ET | Source: Herantis Pharma plc

Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer

Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and...
June 25, 2026 02:00 ET | Source: Herantis Pharma plc

Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer

Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and...